Concert Pharma (CNCE)
NASDAQ:CNCE
Holding CNCE?
Track your performance easily

Concert Pharma (CNCE) Financial Statements

0 Followers

Concert Pharma Financial Overview

Concert Pharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Concert Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 8.00K$ 21.00K$ 0.00$ 13.00K$ 543.00K
Gross Profit-----
EBIT$ -29.61M$ -25.68M$ -36.03M$ -32.95M$ -26.80M
EBITDA$ -29.30M$ -25.37M$ -35.71M$ -32.63M$ -26.43M
Net Income Common Stockholders$ -28.90M$ -23.55M$ -37.73M$ -36.13M$ -26.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 149.53M$ 154.57M$ 109.91M$ 143.10M$ 106.22M
Total Assets$ 171.13M$ 176.39M$ 129.41M$ 165.32M$ 128.21M
Total Debt$ 14.21M$ 14.51M$ 14.79M$ 15.06M$ 15.31M
Net Debt$ -135.32M$ -140.06M$ -95.11M$ -128.03M$ -90.91M
Total Liabilities$ 37.86M$ 48.60M$ 52.84M$ 53.09M$ 29.05M
Stockholders Equity$ 133.27M$ 127.79M$ 76.57M$ 112.22M$ 99.16M
Cash Flow-
Free Cash Flow$ -26.05M$ -24.98M$ -32.42M$ -26.49M$ -18.73M
Operating Cash Flow$ -25.96M$ -24.90M$ -32.32M$ -26.48M$ -18.64M
Investing Cash Flow$ -39.10M$ 34.93M$ -49.95M$ -16.00K$ -99.00K
Financing Cash Flow$ 21.00M$ 69.85M$ 0.00$ 64.47M$ 0.00
Currency in USD

Concert Pharma Earnings and Revenue History

Concert Pharma Debt to Assets

Concert Pharma Cash Flow

Concert Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis